Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Mar 15, 2023; 15(3): 546-561
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.546
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.546
Figure 7 Estimated IC50 of different chemotherapy drugs between the high- and low-risk groups.
A: Oxaliplatin; B: 5-Fluorouracil; C: Irinotecan; D: Cisplatin; E: Wnt_C59; F: KRAS_Inhibitor; G: Gefitinib; H: Erlotinib; I: Nilotinib; J: Afatinib; K: ABT737; L: Paclitaxel. aP < 0.05; bP < 0.01; cP < 0.001.
- Citation: Weng JS, Huang JP, Yu W, Xiao J, Lin F, Lin KN, Zang WD, Ye Y, Lin JP. Mitophagy-related gene signature predicts prognosis, immune infiltration and chemotherapy sensitivity in colorectal cancer. World J Gastrointest Oncol 2023; 15(3): 546-561
- URL: https://www.wjgnet.com/1948-5204/full/v15/i3/546.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i3.546